Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Current Assets: 2020-2022

Historic Current Assets for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $71.9 million.

  • Candel Therapeutics' Current Assets fell 42.96% to $45.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $45.1 million, marking a year-over-year decrease of 42.96%. This contributed to the annual value of $71.9 million for FY2022, which is 15.30% down from last year.
  • According to the latest figures from FY2022, Candel Therapeutics' Current Assets is $71.9 million, which was down 15.30% from $84.9 million recorded in FY2021.
  • In the past 5 years, Candel Therapeutics' Current Assets ranged from a high of $84.9 million in FY2021 and a low of $35.1 million during FY2020.
  • In the last 3 years, Candel Therapeutics' Current Assets had a median value of $71.9 million in 2022 and averaged $64.0 million.
  • As far as peak fluctuations go, Candel Therapeutics' Current Assets skyrocketed by 141.69% in 2021, and later dropped by 15.30% in 2022.
  • Over the past 3 years, Candel Therapeutics' Current Assets (Yearly) stood at $35.1 million in 2020, then soared by 141.69% to $84.9 million in 2021, then decreased by 15.30% to $71.9 million in 2022.